Cutaneous immune-related adverse events among Taiwanese cancer patients receiving immune checkpoint inhibitors link to a survival benefit

Cutaneous immune-related adverse events are common in cancer patients receiving immunotherapies but seldom studied in a comprehensive way of collecting all cancer types with comparisons between different immune-oncology drugs and correlation to patient survival. In this retrospective cohort study, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Yung-Tsu, Lin, Yi-Tsz, Yang, Che-Wen, Chu, Chia-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055047/
https://www.ncbi.nlm.nih.gov/pubmed/35487955
http://dx.doi.org/10.1038/s41598-022-11128-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055047/
https://www.ncbi.nlm.nih.gov/pubmed/35487955
http://dx.doi.org/10.1038/s41598-022-11128-5

Ejemplares similares